@article{VortkampThiasGessleretal.1991, author = {Vortkamp, A. and Thias, U. and Gessler, Manfred and Rosenkranz, W. and Kroisel, P. M. and Tommerup, N. and Kruger, G. and Gotz, J. and Pelz, L. and Grzeschik, Karl-Heinz}, title = {A somatic cell hybrid panel and DNA probes for physical mapping of human chromosome 7p}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59217}, year = {1991}, abstract = {No abstract available}, subject = {Biochemie}, language = {en} } @article{WolfKlugHackenbergetal.1992, author = {Wolf, Markus and Klug, J{\"o}rg and Hackenberg, Reinhard and Gessler, Manfred and Grzeschik, Karl-Heinz and Beato, Miguel and Suske, Guntram}, title = {Human CC10, the homologue of rabbit uteroglobin: genomic cloning, chromosomal localization and expression in endometrial cell lines}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59206}, year = {1992}, abstract = {No abstract available}, subject = {Biochemie}, language = {en} } @article{GesslerKoenigBruns1992, author = {Gessler, Manfred and K{\"o}nig, A. and Bruns, G. A. P.}, title = {The genomic organization and expression of the WT1 gene}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59195}, year = {1992}, abstract = {The Wilms tumor gene WTl, a proposed tumor suppressor gene, has been identifled based on its location within a homozygous deletion found in tumor tissue. The gene encodes a putative transcription factor containing a Cys/His zinc finger domain. The critical homozygous deletions, however, are rarely seen, suggesting that in many cases the gene may be inactivated by more subtle alterations. To facilitate the seareh for smaller deletions and point mutations we have established the genomic organization of the WTl gene and have determined the sequence of all 10 exons and flanking intron DNA. The pattern of alternative splicing in two regions has been characterized in detail. These results will form the basis for future studies of mutant alleles at this locus.}, subject = {Biochemie}, language = {en} } @article{GesslerGrupeGrzeschiketal.1992, author = {Gessler, Manfred and Grupe, Andrew and Grzeschik, Karl-Heinz and Pongs, Olaf}, title = {The potassium channel gene HK1 maps to human chromosome 11p14.1, close to the FSHB gene}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59184}, year = {1992}, abstract = {Transiently activating (A-type) potassium (K) channels are important regulators of action potential and action potential firing frequencies. HK1 designates the firsthuman cDNA that is highly homologous to the rat RCK4 cDNA that codes for an A-type K-channel. The HK1 channel is expressed in heart. By somatic cell hybrid analysis, the HK1 gene has been assigned to human chromosome 11p13-pl4, the WAGR deletion region (Wilms tumor, aniridia, genito-urinary abnormalities and mental retardation). Subsequent pulsed field gel (PFG) analysis and comparison with the well-established PFG map of this region localized the gene to 11p14, 200-600 kb telomeric to the FSHB gene.}, subject = {Biochemie}, language = {en} } @article{PoulatMorinKonigetal.1993, author = {Poulat, F. and Morin, D. and Konig, A. and Brun, P. and Giltay, J. and Sultan, C. and Dumas, R. and Gessler, Manfred and Berta, P.}, title = {Distinct molecular origins for Denys-Drash and Frasier syndromes}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59172}, year = {1993}, abstract = {The direct involvment of the Wilm's tumor suppressor gene (WTl) in Denys-Drash syndrome through mutations within exons 8 or 9 has recently been established. The absence of such alterations in three patients with Frasier syndrome provides a molecular basis for distinguishing these two syndromes that are associated with streak gonads, pseudohermaphroditism and renal failure.}, subject = {Biochemie}, language = {en} } @article{KonigJakubiczkaWieackeretal.1993, author = {Konig, Anja and Jakubiczka, Sybille and Wieacker, Peter and Schl{\"o}sser, Hans W. and Gessler, Manfred}, title = {Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59167}, year = {1993}, abstract = {No abstract available}, subject = {Biochemie}, language = {en} } @phdthesis{Heisig2011, author = {Heisig, Julia}, title = {Identifizierung neuer Zielgene der Hey bHLH Transkriptionsfaktoren}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-65053}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2011}, abstract = {Der Notch Signalweg spielt w{\"a}hrend der Embryonalentwicklung eine zentrale Rolle in der Spezifizierung des Zellschicksales, der Proliferation und der Kommunikation benachbarter Zellen. Die Hey bHLH Transkriptionsfaktoren sind Zielgene des Notch-Signalweges und besitzen wichtige Funktionen in der kardiovaskul{\"a}ren Entwicklung. Hey2 Knockout (KO) M{\"a}use und Hey1/HeyL Doppelknockout-M{\"a}use (DKO) sind gekennzeichnet durch eine fehlerhafte Ausbildung der Herzscheidewand und der Herzklappen und durch eine unzureichende Differenzierung w{\"a}hrend der Blutgef{\"a}ßentwicklung. Ziel dieser Arbeit war es, neue Zielgene der Hey Proteine zu finden, um ihre Funktion in der Organentwicklung und die Auspr{\"a}gung der Hey KO Maus-Ph{\"a}notypen besser verstehen zu k{\"o}nnen. Dazu wurde als Methode eine Kombination aus Microarray-Analyse und Chromatinimmunpr{\"a}zipitation (ChIP) gew{\"a}hlt, um gleichzeitig einen {\"U}berblick {\"u}ber die regulierten Zielgene und der direkt gebundenen Promotoren zu gewinnen. Als Zellkulturmodell wurden HEK293-Zellen genutzt, die doxyzyklin-induzierbar Flag-markiertes Hey1, bzw. Hey2 Protein {\"u}berexprimieren. Eine Microarray-Analyse nach {\"U}berexpression von Hey1, bzw. Hey2 ergab insgesamt ca. 100 bis zu 5-fach herunterregulierte Zielgene und nur f{\"u}r Hey2 15 Gene, die st{\"a}rker als 2-fach hochreguliert waren. Eine ChIP mit αFlag-Antik{\"o}rper zeigte eine direkte DNA-Bindung von Hey1, bzw. Hey2, im proximalen Promotorbereich von 4 herunterregulierten Zielgenen (HEY1, BMP2, KLF10 und FOXC1). Ist jedoch die DNA-bindende basische Dom{\"a}ne des Hey1-Proteins deletiert, bzw. durch Aminos{\"a}ureaustausche (3 Arginine zu 3 Lysine) vermutlich nicht mehr DNA-bindend, kann eine Herunterregulation der Zielgene nach {\"U}berexpression der Hey1-Mutanten nicht mehr festgestellt werden. Ebenso kann eine Bindung der Hey1-Mutanten an die ausgew{\"a}hlten Promotoren von HEY1, BMP2, KLF10 oder FOXC1 mit ChIP nicht mehr nachgewiesen werden. Dies deutet darauf hin, dass die basische Dom{\"a}ne essentiell f{\"u}r die DNA-Bindung und f{\"u}r die Funktion der Hey Proteine ist. Mit ChIP-PET und anschließender Hochdurchsatz-Sequenzierung wurde ein genomweiter Screen der Hey1- und der Hey2-Bindungsstellen in HEK293-Zellen durchgef{\"u}hrt. F{\"u}r Hey1 wurden 1453 Zielgene, f{\"u}r Hey2 4288 Zielgene bestimmt, wobei 1147 Gene gemeinsame Zielgene von Hey1 und Hey2 waren. Obwohl die Bindungsstellen in 5'- und 3'-Richtung von kodierenden Sequenzen und auch in Exons und Introns lokalisiert waren, waren 55 \%, bzw. 49 \% aller Bindungsstellen f{\"u}r Hey1, bzw. Hey2 im proximalen Promotorbereich von -0,5 kb und im ersten Exon lokalisiert. Eine in silico Analyse des Bindemotivs deutete auf eine repetitive GC-haltige Sequenz hin, die vermutlich in CpG Inseln lokalisiert ist. Diese Ergebnisse weisen auf eine direkte Regulation der Transkriptionsmaschinerie durch die Hey Proteine hin. Ein Vergleich der Zielgene aus den Microarray-Analysen mit den ChIP-PET Daten zeigte einen hohen Anteil an herunterregulierten Genen mit Bindestellen, die direkt von Hey gebunden waren. W{\"a}hrend 60 \% der herunterregulierten Hey2 Zielgene in der ChIP-PET Analyse eine direkte DNA-Bindung zeigen, weisen nur 20 \% der hochregulierten Gene Bindestellen f{\"u}r Hey2 auf. Dies spricht f{\"u}r eine {\"u}berwiegende Repressorfunktion der Hey Proteine. Um zu {\"u}berpr{\"u}fen, inwieweit die Hey Proteine zelltypspezifisch verschiedene Zielgene regulieren, wurden embryonale Stammzellen (ES-Zellen) generiert, die ebenfalls doxyzyklin-induzierbar Hey1, bzw. Hey2 {\"u}berexprimieren. Diese ES-Zellen konnten effektiv zu Kardiomyozyten differenziert werden, so dass auch in diesen Zellen eine Hey {\"U}berexpression induziert und somit eine Genexpressionsanalyse durchgef{\"u}hrt werden konnte. Microarray Analysen der ES-Zellen und Kardiomyozyten ergaben mehr hoch- als herunterregulierte Gene im Vergleich zu HEK293-Zellen. Die {\"U}berlappung an gemeinsam regulierten Zielgenen in HEK293, ES-Zellen und Kardiomyozyten war sehr gering. Nur zwei Hey2-Zielgene wurden gleichzeitig in HEK293 und ES-Zellen st{\"a}rker als 2-fach reguliert (Hes1, Zic2). Diese geringe {\"U}berlappung deutet auf ein enges zelltypspezifische Regulationspotential hin. Eine Genontologie-Analyse aller Zielgene zeigte Interaktionen der Hey Proteine mit verschiedenen Signalwegen (z.B. TGFβ-, Id- oder Wnt-Signalweg), die alle unersetzlich in fr{\"u}hen Entwicklungsprozessen sind. Diese Ergebnisse deuten darauf hin, dass die Hey Proteine zelltypspezifisch die Expression von Genen aus verschiedenen Signalwegen beeinflussen und modulieren k{\"o}nnen. Weiterhin er{\"o}ffnen diese Daten neue M{\"o}glichkeiten f{\"u}r zuk{\"u}nftige Forschung, um die Rolle der Hey Proteine in der fr{\"u}hen Organentwicklung genauer ergr{\"u}nden.}, subject = {Gen notch}, language = {de} } @phdthesis{Schneider2011, author = {Schneider, Matthias}, title = {Characterisation of Metalloprotease-mediated EGFR Signal Transactivation after GPCR Stimulation}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-65105}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2011}, abstract = {In the context of metalloprotease-mediated transactivation of the epidermal growth factor receptor, different monoclonal antibodies against ADAM17 / TACE were characterized for their ability to block the sheddase. Activity of some of them was observed at doses between 2µg/mL and 10µg/mL. Kinetic analyses showed their activity starting at around 30 minutes. In cellular assays performed with the antibodies, especially upon treatment of cells with sphingosine-1-phosphate a reduction in proliferation was observed with some candidates. Moreover this study provides potential new roles for ß-Arrestins. Their involvement in the triple membrane-passing signal pathway of EGFR transactivation was shown. Furthermore, in overexpressing cellular model systems, an interaction between ADAM17 and ß-Arrestin1 could be observed. Detailed analysis discovered that phosphorylation of ß-Arrestin1 is crucial for this interaction. Additionally, the novel mechanism of UV-induced EGFR transactivation was extended to squamous cell carcinoma. The mechanism happens in a dose dependent manner and requires a metalloprotease to shed the proligand Amphiregulin. The involvement of both ADAM9 and ADAM17, being the metalloproteases responsible for this cleavage, was shown for SCC9 cells.}, subject = {Epidermaler Wachstumsfaktor-Rezeptor}, language = {en} } @article{HenryHooversBarichardetal.1993, author = {Henry, Isabelle and Hoovers, Jan and Barichard, Fernande and Berth{\´e}as, Marie-Francoise and Puech, Anne and Prieur, Fabienne and Gessler, Manfred and Bruns, Gail and Mannens, Marcel and Junien, Claudine}, title = {Pericentric intrachromosomal insertion responsible for recurrence of del(11)(p13p14) in a family}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59157}, year = {1993}, abstract = {The combined use of qualitative and quantitative analysis of I I p I 3 polymorphic markers tagether with chromosomal in situ suppression hybridization (CISS) with biotin labeled probes mapping to I I p allowed us to characterize a complex rearrangement segregating in a family. We detected a pericentric intrachromosomal insertion responsible (or recurrence of del( I I )(p 13p 14) in the family: an insertion of band I I p 13-p 14 carrying the genes for predisposition to Wilms' tumor, WT I, and for aniridia, AN2, into the long arm of chromosome I I in II q 13-q 1<4. Asymptomatic balanced carriers were observed over three generations. Classical cytogenetics had failed to detect this anomaly in the balanced carriers, who were first considered to be somatic mosaics for del( II )(p 13). Two of these women gave birth to children carrying a deleted chromosome II. most likely resulting from the loss of the I I p 13 band inserted in I I q. Although in both cases the deletion encompassed exactly the same maternally inherited markers, there was a wide Variation in clinical expression. One child, with the karyotype 46,XY,del(ll)(pllpl4), presented the full-blown WAGR syndrome with anlridia, mental retardation, Wilms' tumor, and pseudohermaphroditism, but also had proteinuria and glomerular sclerosis reminiscent of Drash syndrome. In contrast, the other one, a girl with the karyotype 46,XX,del( I I )(p I 3), only had aniridia. Although a specific set of mutational sites has been observed in Drash patients, these findings suggest that the loss of one copy of the WTI gene can result in similar genital and kidney abnormalities.}, subject = {Biochemie}, language = {en} } @article{GesslerKonigMooreetal.1993, author = {Gessler, Manfred and Konig, Anja and Moore, Jay and Qualman, Steven and Arden, Karen and Cavenee, Webster and Bruns, Gail}, title = {Homozygous inactivation of WTI in a Wilms' tumor associated with the WAGR syndrome}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59146}, year = {1993}, abstract = {Wilms' tumor is a childhood nephroblastoma that is postulated to arise through the inactivation of a tumor suppressor gene by a two-hit mechanism. A candidate II p 13 Wilms' tumor gene, WTI, has been cloned and shown to encode a zinc finger protein. Patients with the WAGR syndrome (Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation) have a high risk of developing Wilms' tumor and they carry constitutional deletions of one chromosome II allele encompassing the WTI gene. Analysis of the remaining WTI allele in a Wilms' tumor from a WAGR patient revealed the deletion of a single nucleotide in exon 7. This mutation likely played a key role in tumor formation, as it prevents translation of the DNA-binding zinc finger domain that is essential for the function of the WTI polypeptide as a transcriptional regulator.}, subject = {Biochemie}, language = {en} }